Insulin resistance and PCOS: chicken or egg?
The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Abstract
PCOS is a common and heterogeneous endocrine disorder in women of reproductive age, frequently associated with metabolic abnormalities. It was estimated that about 75% of these subjects have an impairment of insulin action, as measured by gold standard methods. While the relationship between insulin resistance and PCOS is consistently shown by a number of studies, the mechanisms underlying its primary origin still remains an unsolved issue. Insulin resistance and the associated hyperinsulinemia can induce both the endocrine and reproductive traits of PCOS. However, androgen excess, in turn, can impair insulin action, directly and/or through several changes occurring in different tissues. Body fat excess, which is another common feature in these women, can contribute to worsening the whole picture. Nevertheless, insulin resistance may also be found in many normal-weight individuals. Endocrine and metabolic abnormalities can develop in different moments, and probably there is fetal programming of these alterations. However, a number of vicious circles, with bidirectional relationships between androgen excess and insulin resistance, and with the contribution of several other factors, make it extremely difficult to understand where this process really originates. This review summarizes available evidence on this topic, in order to better understand the complex relationships linking hyperandrogenism and impaired insulin action in women with PCOS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Using gold standard procedures, it was estimated that approximately 75% of patients with PCOS had insulin resistance and that the endocrine and reproductive characteristics of PCOS can be brought on by insulin resistance [27].”
From Efficacy of WeChat-Based Digital Intervention Versus Metformin in Women With Polycystic Ovary Syndrome: Randomized Controlled Trial (2024) · cites this paper as [27]
In the citing paper
“Using gold standard procedures, it was estimated that approximately 75% of patients with PCOS had insulin resistance and that the endocrine and reproductive characteristics of PCOS can be brought on by insulin resistance [27].”
From Efficacy of WeChat-Based Digital Intervention Versus Metformin in Women With Polycystic Ovary Syndrome: Randomized Controlled Trial (2024) · cites this paper as [27]
In the citing paper
“Consequently, HOMA-IR was selected in this study as the major end point as it plays a significant role in the onset and progression of PCOS.”
From Efficacy of WeChat-Based Digital Intervention Versus Metformin in Women With Polycystic Ovary Syndrome: Randomized Controlled Trial (2024) · cites this paper as [27]
In the citing paper
“Insulin levels, which mainly drive these surrogate indexes, depend on several factors, not only insulin sensitivity and glucose levels. In particular, obesity, age, androgen levels, metabolism and clearance of insulin, and enzymatic degradation of the insulin–receptor complex are perhaps more valuable than insulin itself [44].”
From Controversies in the Pathogenesis, Diagnosis and Treatment of PCOS: Focus on Insulin Resistance, Inflammation, and Hyperandrogenism (2022) · cites this paper as [44]
In the citing paper
“The result of all the processes described above is impaired glucose transport into cells by insulin-dependent membrane GLUT 4 transporters, reduced glycogen synthesis and decreased inhibition of hepatic gluconeogenesis. This leads to hyperglycemia and to compensatory hyperinsulinemia.”
From The Role of Glp-1 Receptor Agonists in Insulin Resistance with Concomitant Obesity Treatment in Polycystic Ovary Syndrome (2022) · cites this paper as [61]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
Diamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947
Criteria, Prevalence, and Phenotypes of Polycystic Ovary Syndrome
Lizneva, D., Suturina, L., Walker, W., Brakta, S., Gavrilova-Jordan, L., & Azziz, R. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.05.003 · Cited by 1,358 · cited 1×
“Based on the generally adopted Rotterdam diagnostic criteria, established in a workshop consensus of the American Society for Reproductive Medicine (ASRM) and the European Society of Human Reproduction and Embriology (ESHRE) [1], it was estimated that its prevalence is at least 10% [2].”
MethodMoran, L. J., Misso, M. L., Wild, R. A., & Norman, R. J. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmq001 · Cited by 1,108
Biological Actions of Androgens
MOORADIAN, A. D., MORLEY, J. E., & KORENMAN, S. G. (1987) · Endocrine Reviews · doi:10.1210/edrv-8-1-1 · Cited by 1,080
Prevalence and Characteristics of the Metabolic Syndrome in Women with Polycystic Ovary Syndrome
Apridonidze, T., Essah, P. A., Iuorno, M. J., & Nestler, J. E. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1045 · Cited by 931
Insulin Degradation: Progress and Potential*
Duckworth, W. C., Bennett, R. G., & Hamel, F. G. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.5.0349 · Cited by 871
Stepto, N. K., Cassar, S., Joham, A. E., Hutchison, S. K., Harrison, C. L., Goldstein, R. F., & Teede, H. J. (2013) · Human Reproduction · doi:10.1093/humrep/des463 · Cited by 747
Using human genetics to understand the disease impacts of testosterone in men and women
The Endometrial Cancer Association Consortium, Ruth, K. S., Day, F. R., Tyrrell, J., Thompson, D. J., Wood, A. R., Mahajan, A., Beaumont, R. N., Wittemans, L., Martin, S., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0751-5 · Cited by 720
Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome
Legro, R. S., Driscoll, D., Strauss, J. F., Fox, J., & Dunaif, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14956 · Cited by 699
Research works printed but not linked: 1
- Johnson T, Kaplan L, Ouyang P, Rizza P (2012) National Institutes of Health evidence-based methodology workshop on polycystic ovary syndrome. NIH EbMW reports. National Institutes of Health, Bethesda 1:1–14. https://www.prevention.nih.gov/sites/default/files/2018-06/FinalReport.pdf. Accessed 31 Mar 2020
Cited by
Items 101–200 of 229
Jin, B., Zhang, Y., Zhang, Z., Yang, G., Pan, Y., Xie, L., Liu, J., & Shen, W. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/8698755 · Cited by 7
“A correlation exists between hyperandrogenemia and the development of IR and hyperinsulinemia [62], and excessive androgen also results in elevated levels of LH and FSH in PCOS patients [63].”
BackgroundNatural History of Polycystic Ovary Syndrome and New Advances in the Epidemiology
Piltonen, T., Arffman, R. K., & Joham, A. E. (2021) · Seminars in Reproductive Medicine · doi:10.1055/s-0041-1735211 · Cited by 7
Huang, W., Liu, C., Ding, L., Li, Y., Zhou, H., Wang, S., & Yang, H. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1327041 · Cited by 6
“Approximately 45%-65% of women with PCOS have insulin resistance (IR), which is considered an initiating factor and plays a key role in the development of PCOS (8, 9).”
BackgroundWang, J., Li, L., Zhou, J., Pan, X., Qi, Q., Sun, H., & Wang, L. (2024) · Drug Discoveries & Therapeutics · doi:10.5582/ddt.2024.01003 · Cited by 7
Cardiorespiratory Fitness in Young Adult Women With a History of Premature Adrenarche
Tennilä, J., Jääskeläinen, J., Utriainen, P., Voutilainen, R., Laitinen, T. P., & Liimatta, J. (2023) · Journal of the Endocrine Society · doi:10.1210/jendso/bvad041 · Cited by 6
“…fitness (CRF), the ability to transit oxygen to muscles under exercise for prolonged periods, was lower in women with PCOS in most of the studies reviewed by Dona et al [8], and correlated negatively with insulin resistance [8], commonly found in both women with PCOS [9] and PA [10].”
Hormone Imbalance in Polycystic Ovarian Syndrome
Bergo, I., Eckert, D., Puşcaş, A., Jîtcă, G., & Tero-Vescan, A. (2023) · Acta Biologica Marisiensis · doi:10.2478/abmj-2023-0002 · Cited by 6
Wang, X., Hou, Y., Zhao, H., Wang, J., Guo, C.-H., Guan, J., Lv, Z., Ma, P., & Han, J. (2023) · World Journal of Gastrointestinal Surgery · doi:10.4240/wjgs.v15.i11.2423 · Cited by 6
Suppressive Role of Lactoferrin in Overweight-Related Female Fertility Problems
Sato, B., Kanai, S., Sakaguchi, D., Yajima, K., Matsumoto, Y., Morohoshi, K., Kagaya, S., Izumo, N., Ichinose, M., Kang, W., et al. (2022) · Nutrients · doi:10.3390/nu14050938 · Cited by 7
“One of the ovulation disorders, polycystic ovary syndrome (PCOS), is caused by hyperandrogenism with insulin resistance in women with hyperglycemia [30].”
BackgroundTilak, J. R., Jain, A., Wadhwa, N., Tilak, H. R., & Ahirwar, A. K. (2022) · Advances in Laboratory Medicine / Avances en Medicina de Laboratorio · doi:10.1515/almed-2021-0098 · Cited by 6
“The relationship between insulin resistance and PCOS has been consistently shown by several studies but what is the cause and what is the effect still remains an unsolved issue [1].”
BackgroundLong, X., Liu, H., Xiong, W., Li, W., He, H., Fu, T., Li, X., Chen, C., Zhang, L., & Liu, Y. (2023) · Gynecological Endocrinology · doi:10.1080/09513590.2023.2223648 · Cited by 7
“The excess insulin promotes androgen production in ovarian theca cells as a response to luteinizing hormone stimulation, and result in follicular arrest and anovulation [10].”
BackgroundAsouri, S. A., Asemi, R., Aghadavod, E., & Jamilian, M. (2024) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000001732 · Cited by 6
“Although the issue of the association between PCOS and insulin resistance has attracted a lot of attention, the primary origin mechanism is not yet fully understood [10] .”
BackgroundThe epigenetic impact of lifestyle factors on metabolic syndrome: A systematic review
Adedeji, T. G. (2025) · Journal of Clinical Sciences · doi:10.4103/jcls.jcls_28_25 · Cited by 5
Kasimanickam, R. K., Kasimanickam, V. R., Ferreira, J. C. P., Kastelic, J. P., & de Souza, F. F. (2025) · Genes · doi:10.3390/genes16070791 · Cited by 5
“The high metabolic demands of lactation and the resulting insulin-resistant state in postpartum cows replicate many features of PCOS, including disrupted folliculogenesis, hyperandrogenism, and ovulatory failure [41,150,151].”
Polycystic Ovary Syndrome and Irritable Bowel Syndrome: Is There a Common Pathway?
Naz, M. S. G., Ghasemi, V., Amirshekari, S., & Tehrani, F. R. (2024) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.477 · Cited by 6
“The prevalence of insulin resistance, impaired glucose intolerance (IGT) and diabetes mellitus is higher in women with PCOS than in healthy women which can induce the reproductive traits of PCOS [97, 98].”
BackgroundHançerlioğulları, N., Tokmak, A., Güney, G., Pekcan, M. K., Koc, E. M., Çandar, T., & Üstün, Y. E. (2022) · Medicine · doi:10.1097/md.0000000000032326 · Cited by 7
“Further prospective studies that longitudinally observe patients in larger groups should be performed to validate the clinical usability of calprotectin levels in PCOS.”
BackgroundInfluentialThe PCOS puzzle: putting the pieces together for optimal care
Dar, M. A., Maqbool, M., & Ara, I. (2023) · International Journal of Adolescent Medicine and Health · doi:10.1515/ijamh-2023-0102 · Cited by 7
da Silva, J. V. M. B., Veiga, A. C., Philbois, S. V., Ribeiro, V. B., Aguilar, B. A., Paixão, T. E. V., Chinellato, N. T., Delgado, J. C. S., Gastaldi, A. C., & de Souza, H. C. D. (2024) · Clinical Endocrinology · doi:10.1111/cen.15163 · Cited by 6
Cannarella, R., Calogero, A. E., Barbagallo, F., Petralia, C. M. B., Aversa, A., Condorelli, R. A., & Vignera, S. L. (2025) · Human Nutrition & Metabolism · doi:10.1016/j.hnm.2025.200331 · Cited by 4
Yang, X., Luo, H., Li, Q., Zhu, W., Fu, L., Chen, L., Li, X., Su, H., Zhang, L., & Huang, Y. (2025) · The FASEB Journal · doi:10.1096/fj.202502661r · Cited by 5
“Approximately 75% of PCOS patients exhibit impaired insulin action, and this insulin resistance, coupled with hyperinsulinemia, is implicated in the development of the syndrome's endocrine and reproductive features [4, 5].”
Zhao, Z., Yan, J., Ding, Y., Wang, Y., & Li, Y. (2023) · PLoS ONE · doi:10.1371/journal.pone.0288414 · Cited by 4
“However, the molecular mechanisms of IR in PCOS seem to vary from other disorders such as obesity and T2DM [19].”
BackgroundInfluentialLi, C., Zhou, L., Zhang, Y., Li, Y., & Zhao, L. (2024) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.16076 · Cited by 4
“It is well known that IR plays a crucial role in the onset of PCOS [11 – 13].”
Liu, Y., Zhang, W., Liu, Z., Zheng, A., Liang, B., Li, H., & Meng, Q. (2024) · Food Science & Nutrition · doi:10.1002/fsn3.4258 · Cited by 4
“Additionally, PCOS is linked to metabolic disorders, such as dyslipidemia, insulin resistance, metabolic syndrome, and obesity, all highly intertwined with energy metabolism (Joham et al., 2022; Moghetti & Tosi, 2021).”
BackgroundXuan, Y., Hong, X., Zhou, X., Yan, T., Qin, P., Peng, D., & Wang, B. (2024) · PeerJ · doi:10.7717/peerj.18194 · Cited by 4
“Moreover, PCOS is related to insulin resistance ( Moghetti & Tosi, 2021 ), obesity ( Simkova et al., 2020 ), type 2 diabetes mellitus ( Livadas et al., 2022 ), cardiovascular diseases ( Livadas et al., 2022 ) and is one cause of infertility ( Pericuesta et al., 2020 ) in reproductive age women.”
The Relationship between Anti-mullerian Hormone and Prolactin Levels in Polycystic Ovarian Syndrome
Güngör, K. (2023) · The Anatolian Journal of Family Medicine · doi:10.5505/anatoljfm.2023.00821 · Cited by 5
“[9] However, the relationship between serum AMH and prolactin levels on the pathogenesis of PCOS has not been comprehensively investigated yet.”
BackgroundZhang, L., Chen, A., Lü, J., Ren, L., & Hu, Z. (2022) · Reproductive Sciences · doi:10.1007/s43032-022-01061-3 · Cited by 4
CORRELAÇÃO DA RESISTÊNCIA À INSULINA EM PORTADORAS DA SÍNDROME DO OVÁRIO POLICÍSTICO
Gomes, G. S., Melo, J. V. D. O., Barros, P. S. D., & Lima, T. D. A. (2022) · Revista Multidisciplinar em Saúde · doi:10.51161/rems/3577 · Cited by 3
Singh, A., Tripathi, R., Gupta, R. K., Rashid, R., & Jha, R. K. (2024) · Reproductive Biology · doi:10.1016/j.repbio.2024.100862 · Cited by 4
Escalona, X. A., Ayala, R., Cortez, K. L., Sánchez, S. F., Tomé-Dehesa, T., Díaz-Hernández, V., Larqué, C., & Escalona, R. (2025) · Biology · doi:10.3390/biology14060592 · Cited by 5
“PCOS patients often develop a compensatory hyperinsulinemia as a consequence of insulin resistance; furthermore, it is widely considered that hyperinsulinemia is a major driver of hyperandrogenism in PCOS [47].”
Cardiometabolic risk in women with polycystic ovary syndrome: a comprehensive review
Cagnacci, A., ANTONELLI, G. A., VATTERONI, G., & Xholli, A. (2025) · Minerva Obstetrics and Gynecology · doi:10.23736/s2724-606x.25.05732-x · Cited by 4
Nutrition interventions in women with polycystic ovary syndrome: a systematic review
Akbaş, E., Samancı, M., & Öztürk, Y. E. (2026) · European Journal of Nutrition · doi:10.1007/s00394-026-04030-7 · Cited by 3
Xie, J., Xu, X. L., Chen, Y., Lu, Y., Liu, M., Feng, Y., Qi, C., & Liu, S. (2025) · Cell Biology and Toxicology · doi:10.1007/s10565-025-10047-1 · Cited by 4
Prediction a woman having Polycystic Ovary Syndrome (PCOS) those having Insulin Resistance (IR)
Talib, I., Khadija, S., Khan, A. M., Akram, S., Akhtar, M. K., Willayat, F., & Iftikhar, A. (2022) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs221626 · Cited by 3
Freeman, R. G. (2022) · Springer eBooks · doi:10.1007/978-3-030-92589-5_7 · Cited by 3
Emerging Role of the ceRNA-Based MALAT-1-miRNA Network in Polycystic Ovary Syndrome
Dari, M. A. G., Keivan, M., Moramezi, F., Saadati, N., Nikbakht, R., & Farzaneh, M. (2023) · Journal of Obstetrics Gynecology and Cancer Research · doi:10.30699/jogcr.8.4.308 · Cited by 3
Tabatabaie, S. F. S., Salahshoorifar, I., Pouresmaeili, F., Golloo, Z. H., Aarabi, A., Oskooei, V. K., & Vatannejad, A. (2024) · Gene · doi:10.1016/j.gene.2024.148906 · Cited by 2
Üçgül, E., Menekşe, B., Demirci, H., & Çakal, E. (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02761-8 · Cited by 2
Bakar, S., Arpa, M., Kuruca, N., & Şentürk, Ş. (2025) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.70725 · Cited by 2
Mashhadi, F., Ghaebi, N. K., Rakhshandeh, H., Khadem‐Rezaiyan, M., Roudi, F., & Nematy, M. (2026) · Journal of Ovarian Research · doi:10.1186/s13048-025-01867-0 · Cited by 3
“Considering the pathophysiology of conditions like PCOS, chronic low-grade inflammation and metabolic abnormalities such as insulin resistance and dyslipidemia play crucial roles in ovarian dysfunction and infertility [46, 93–95].”
Tapilskaya, N. I., Sazhina, I. N., Andreeva, M. D., & Sorokina, O. V. (2022) · GYNECOLOGY · doi:10.26442/20795696.2022.2.201393 · Cited by 2
“Нарушение действия инсулина при СПЯ обусловлено пострецепторными внутриклеточными нарушениями, например расстройством сигнальной трансдукции за счет дефекта фосфатидилинозитола (ФИ) [4].”
InfluentialCombining proteomic markers to construct a logistic regression model for polycystic ovary syndrome
Tong, C., Wu, Y., Zhuang, Z., Wang, Z., & Yu, Y. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1227252 · Cited by 2
Zaidieva, Y. Z., Balan, V. E., & Tsar’kova, A. V. (2023) · Russian Bulletin of Obstetrician-Gynecologist · doi:10.17116/rosakush20232306125 · Cited by 2
Kamińska, K., Świderska, B., Malinowska, A., & Grzesiak, M. (2024) · Journal of Proteomics · doi:10.1016/j.jprot.2024.105318 · Cited by 2
Talib, M. F., & Ulaiwi, A. H. (2025) · IRAQI JOURNAL OF AGRICULTURAL SCIENCES · doi:10.36103/8r7rtx23 · Cited by 2
The multifarious role of insulin in PCOS: From pathophysiology to therapeutic management
Moghetti, P. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823045-9.00002-x · Cited by 3
Self-citationТатарчук, Т. Ф., Tutchenko, T. М., & Бурка, О. А. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.103808 · Cited by 2
Magnesium and zinc levels in obese women with PCOS
Yousif, A. W., & Al-Jawadi, Z. A. M. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns5.12033 · Cited by 2
“Insulin resistance causes an accumulation of insulin in the blood, which in turn stimulates the ovaries to generate more androgens (Moghetti & Tosi, 2021).”
BackgroundSun, Y., Liu, X., Ding, Q., Yin, S., & Yang, H. (2022) · Medicine · doi:10.1097/md.0000000000032234 · Cited by 3
Wu, X., ZHANG, S.-K., He, H. R., Wang, Y., Li, J., Gao, J., Cong, J., Feng, J., & Zhu, M. (2022) · Research Square · doi:10.21203/rs.3.rs-1384361/v1 · Cited by 2
Ghamsari, S. R., Siahkal, S. F., Zahmatkesh, B. H., & Ebrahimi, E. (2024) · Gynecology and Obstetrics Clinical Medicine · doi:10.1136/gocm-2024-000007 · Cited by 1
de Souza, E. S. A., Mendes, B. S., Simões, M. C. C., Miranda, Y. I., de Oliveira, D. A., & Reis, M. C. (2024) · Revista Contemporânea · doi:10.56083/rcv4n10-097 · Cited by 1
Han, Y., Zhang, J., Li, Q., Wan, B., & Xie, C. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1619618 · Cited by 1
Shahed‐Morshed, M., Morshed, M. S., Hasan, M., Banu, H., Sultana, N., Sultana, N., Siddika, M. A., Islam, M. R., Mahrukh, H., Ferdousi, T., et al. (2025) · Reproductive Medicine and Biology · doi:10.1002/rmb2.70015 · Cited by 2
“Late sleep patterns may exacerbate hormonal imbalances and metabolic dysregulation, including insulin resistance, which are key components of the syndrome [26].”
Yang, X., Yang, H. Y., Shen, D., Zhang, Q., & Zhu, C. (2025) · Frontiers in Genetics · doi:10.3389/fgene.2025.1634588 · Cited by 1
“Hyperandrogenism and insulin resistance have a bidirectional relationship, which forms a vicious cycle in the endocrine status of patients with PCOS (Moghetti and Tosi, 2021).”
Tosi, F., Zanolin, M. E., Garofalo, S., Gremes, V., Zoppini, G., & Moghetti, P. (2026) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02800-4 · Cited by 1
Self-citationCangfu Daotan decoction treats PCOS-IR through the IL6/JAK2/STAT3/FOXO4 signaling pathway
Ju, W., ZHANG, Q., Wang, Y., 潘克英, Li, Y., Zhao, S., & Lian, F. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1661000 · Cited by 1
“The prevalence of IR is reported to be as high as 75% among patients with PCOS (5).”
Vitamin D status tracks inflammation perfusion and pregnancy in polycystic ovary syndrome
Wang, K., Wang, R., Cai, Z., Ma, J. H., Li, G., & Wang, F. (2026) · iScience · doi:10.1016/j.isci.2026.116120 · Cited by 1
Myo-inositol in polycystic ovary syndrome: a systematic review and positioning of its use
Filho, D. R., Nogueira‐de‐Almeida, C. A., & Filho, I. J. Z. (2022) · International Journal of Nutrology · doi:10.54448/ijn22201 · Cited by 1
Roozbeh, J., Janfeshan, S., Afshari, A., Doostkam, A., & Yaghobi, R. (2022) · PubMed Central · doi:10.22088/ijmcm.bums.11.2.168 · Cited by 1
“Its diagnosis is based on clinical complications such as hyperandrogenism (clinical and /or biochemical) and ovarian dysfunction (chronic oligoanovulation and/or micropolycystic morphology of the ovary) (21).”
BackgroundInfluentialTaddeo, S. D., Andreadi, A., Minasi, A., D’Ippolito, I., Borelli, B., Meloni, M., Romano, M., Ruotolo, V., Cacciotti, L., Rizzo, G., et al. (2023) · SAGE Open Medical Case Reports · doi:10.1177/2050313x231178404 · Cited by 1
Gul, U. J., Akhtar, S., Tabassum, H., Khalil, A. A., & Nawaz, Q. (2023) · Pakistan Armed Forces Medical Journal · doi:10.51253/pafmj.v73i3.8914 · Cited by 1
Taleb, M. F., & Ulaiwi, A. H. (2023) · IRAQI JOURNAL OF AGRICULTURAL SCIENCES · doi:10.36103/ijas.v54i5.1827 · Cited by 1
GRg1 Ameliorates Insulin Resistance Through Activation of the PI3K/AKT/GSK-3β Pathway in HepG2 Cells
Shen, X., Jin, Y., Chen, Y., & Yang, H. (2023) · Pharmacognosy Magazine · doi:10.1177/09731296231198284 · Cited by 1
“…which is also closely associated with many diseases, including metabolic dysfunction-associated fatty liver disease (Sakurai et al., 2021), polycystic ovary syndrome (Moghetti & Tosi, 2021), cardiovascular disease (Hill et al., 2021), and Alzheimer’s disease (AD) (Berlanga-Acosta et al., 2020).”
BackgroundEffects of Acupuncture Treatment on Polycystic Ovary Syndrome (PCOS)
Ramanathan, G. (2023) · Obstetrics and gynecology. · doi:10.5772/intechopen.113799 · Cited by 2
Pinto, L. H., de Lima, D. D., Lorenzi, J. B., Giaretta, F. L., Giaretta, D. V., & Massinhan, B. B. (2023) · Saúde Coletiva (Barueri) · doi:10.36489/saudecoletiva.2023v13i88p13394-13394 · Cited by 2
Ji, L., Li, S., Yuan, T., Li, S., Shu, R., & Yang, H. (2025) · Lipids · doi:10.1002/lipd.12429 · Cited by 1
30/w mit unerfülltem Kinderwunsch: Vorbereitung auf die Facharztprüfung: Fall 55
Kannenberg, S. (2021) · Der Internist · doi:10.1007/s00108-021-01068-z
Searching for biomarkers in the progression from polycystic ovary syndrome to endometrial carcinoma
Lu, Z., & Gao, Y. (2021) · Clinical and Experimental Obstetrics & Gynecology · doi:10.31083/j.ceog4805180
Dieta chetogenica, fertilità femminile e sindrome dell’ovaio policistico
Barrea, L., Verde, L., Tarsitano, M. G., & Muscogiuri, G. (2022) · L Endocrinologo · doi:10.1007/s40619-022-01120-6
Kong, F., Zhou, Y., Lu, Y., Ren, C., Chen, M., Jia, R., Chen, J., & Ma, Y. (2022) · Research Square · doi:10.21203/rs.3.rs-2083076/v1 · Cited by 1
van Trotsenburg, M., Luikenaar, R. A. C., & Meriggiola, M. C. (2022) · Cambridge University Press eBooks · doi:10.1017/9781108899987.012
Benign Gynecological Conditions in Transgender and Gender Diverse People
van Trotsenburg, M., Meriggiola, M. C., & Luikenaar, R. A. C. (2022) · Cambridge University Press eBooks · doi:10.1017/9781108899987.015 · Cited by 1
Kaur, B. D., Kaur, P., Garg, R., Gupta, S., & Anju, A. (2023) · INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH · doi:10.36106/ijsr/6700342
Boldori, B. P., Pires, L. R. E., Cavalli, A. P., Friedrich, A. P., Hammes, B., Sampaio, E., Bettes, P. S. L., & Bettes, J. B. (2023) · Seven Editora eBooks · doi:10.56238/devopinterscie-124
GÜRKAN, N. (2023) · Anadolu Kliniği Tıp Bilimleri Dergisi · doi:10.21673/anadoluklin.1183228 · Cited by 1
La diagnosi della sindrome dell’ovaio policistico: problemi ancora aperti
Moghetti, P. (2024) · L Endocrinologo · doi:10.1007/s40619-023-01406-3
“Spesso questa condizione viene desunta dalla presenza di iperinsulinemia, ma vi sono chiare evidenze che questo indice surrogato è inadeguato, se applicato al singolo individuo, dato che i li-velli di insulina sono modulati da numerosi fattori e non solo dalla sensibilità all’insulina [5, 18].”
Self-citationLiu, C., Ding, L., Li, Y., Wang, P., Lin, J., Yang, H., & Mu, L. (2024) · doi:10.22541/au.170671018.89409562/v1
Rosin, B. E., Dalri, I. V., Franchin, K. D. O., França, J. C. E. D., Santos, L. H. D., Alzahrani, Q. E., Pinto, L. H., & de Lima, D. D. (2024) · Arquivos de Ciências da Saúde da UNIPAR · doi:10.25110/arqsaude.v28i1.2024-10550 · Cited by 4
Rashed, S. H., Al-Abachi, S. Z., & Hamoo, R. A. M. (2024) · Egyptian Journal of Veterinary Science · doi:10.21608/ejvs.2024.271704.1865
“This insulin spike, in unison with luteinizing hormone [LH], stimulates androgen production in the ovaries [9-10].”
BackgroundMetabolic Syndrome Severity Score in Subjects with and without Poly Cystic Ovarian Syndrome
Khan, S. H., Hafeez, A., Shahid, R., Noor, C. Q. U. H., Hafeez, J., & Gillani, M. (2024) · Pakistan Armed Forces Medical Journal · doi:10.51253/pafmj.v74i5.8626
Liu, C., Lin, H., Xue, L., Xu, H., Zhong, H., & Que, C. (2024) · Clinical and Experimental Obstetrics & Gynecology · doi:10.31083/j.ceog5111252
“IR is also considered a vital factor in the regulation of energy metabolism and the folliculogenesis and may contribute to infertility caused by PCOS [ 4,5,7].”
Partash, N., Ghamsari, S. R., Shirinbolagh, Z. E., & Ebrahimi, E. (2025) · Journal of Nursing and Midwifery Sciences · doi:10.5812/jnms-153735
Ernest, D. K., Collier, A., Chandrasekhar, A., Xie, L., Darraji, S., Patel, J. R., Almandoz, J. P., & Messiah, S. E. (2025) · Women s Health Reports · doi:10.1089/whr.2024.0143 · Cited by 4
“38 Consequently, long-term accumulation of subcutaneous fat promotes insulin secretion and represses its clearance, inevitably leading to insulin resistance and the development of MetS.”
Pizo, G. V. (2024) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2024.tde-17012025-112947
Asociación del síndrome de ovario poliquístico e hígado graso en mujeres: revisión de la literatura
Vergel, D. C. A., & Quintero, C. Y. S. (2025) · Revista Colombiana de Gastroenterología · doi:10.22516/25007440.1238 · Cited by 1
Нарушение менструального цикла у девочек-подростков с сахарным диабетом 1-го типа
Tyrtova, L. V., Скобелева, К. В., & Рогожина, Е. Д. (2025) · Children s medicine of the North-West · doi:10.56871/cmn-w.2025.43.80.011
«Metabolic health» and endothelial function in women with polycystic ovary syndrome
Tsar’kova, A. V., Balan, V. E., Orazov, M. R., Тихомирова, Е. В., Orlova, S. A., Сергеевна, Ж. А., & Titchenko, Y. P. (2025) · Russian Bulletin of Obstetrician-Gynecologist · doi:10.17116/rosakush20252505127
Zhang, Q., Cao, L., Wang, Y.-M., Wang, X., Cao, X., Li, P., Wang, Y., Hu, X.-D., & Shi, X. (2025) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-4292-2025-0034
“Early detection of liver fibrosis through elastography might help identify patients at risk of poor glycaemic control, allowing for more targeted and effective interventions (11).”
Metabolic complications in a large cohort of Portuguese women with hirsutism-related disorders
Pinto, J., Cera, N., & Pignatelli, D. (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02744-9 · Cited by 1
Mehrhof, S. Z. (2024) · Apollo (University of Cambridge) · doi:10.17863/cam.117708
Decoding genetic associations of female reproductive health traits
Pujol‐Gualdo, N. (2024) · DSpace repository (University of Tartu)
Metabolic health outcomes among women with polycystic ovary syndrome
Kumarendran, B. (2024) · University of Birmingham Institutional Research Archive (University of Birmingham) · Cited by 3
Mo, T., Qiu, Y., He, S., Wang, G., Li, B., Shen, Q., Nie, X., Wei, J., Li, N., Pang, B., et al. (2025) · Journal of Ovarian Research · doi:10.1186/s13048-025-01918-6 · Cited by 1
“IR plays an important role in the pathogenesis of PCOS [57], as it can induce endocrine abnormalities, leading to excessively elevated androgen levels, which, in turn, lead to impaired INS function, creating a vicious cycle [42].”
Silencing Inflammation: Nano-Antioxidants and Immunomodulators in PCOS Management
Kumari, R., & Rani, P. (2025) · doi:10.70593/978-93-7185-087-2_4
Hormonal and metabolic profiles in teenagers and young adults with polycystic ovary syndrome (PCOS)
Bareja, A., Adamczyk, A., Seman, A., Kacalska‐Janssen, O., Jach, R., & Piróg, M. M. (2026) · Endocrine · doi:10.1007/s12020-025-04487-2
“On the other hand, PCOS-related hyperandrogenemia also lead to IR [ 12 ].”
Ramachandran, V., Naarayanan, S., Kumar, K. B., Murugan, G., & Mohanty, B. (2026) · Journal of Family & Reproductive Health · doi:10.18502/jfrh.v19i4.21073
Liu, Y., Gong, Y., Feng, J., Ge, H., Zhu, M., Yu, H., Gao, J., & Wu, X. (2026) · Research Square · doi:10.21203/rs.3.rs-8643615/v1
A Lifecourse Perspective on Polycystic Ovary Syndrome (PCOS): Bridging Gaps in Research and Practice
(2026) · Frontiers research topics · doi:10.3389/978-2-8325-7544-4
Sympathetic neural control of blood pressure across the premenopausal lifespan
Saboune, J., Boyes, N. G., Limberg, J. K., & Usselman, C. W. (2026) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00739.2025
Sengupta, P., Bagchi, S., Nasir, M., Hathat, M., Yaghi, M., Hamshari, A. O., Ahmed, I. M., Barakat, M. I., Ansari, A. K., Kamel, S., et al. (2026) · Obesity Medicine · doi:10.1016/j.obmed.2026.100698
Tersigni, C., Beneduce, G., Onori, M., Sannino, F., Petrecca, A., Simone, N. D., & Ghi, T. (2026) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2026.2647317
Metadata
- Authors
- Moghetti, P., & Tosi, F.
- Affiliations
- University of Verona (IT)
- Corresponding author
- Moghetti, P.
- ORCID
- Venue
- Journal of Endocrinological Investigation
- Published
- 2020-07-09
- Volume
- 44
- Issue
- 2
- Pages
- 233-244
- ISSN
- 0391-4097 (ISSN-L)
- 1720-8386
- OpenAlex
- W3041550542
- Cited by
- 209
- References
- 92
- Citations by year
- 2026: 30 · 2025: 32 · 2024: 36 · 2023: 48 · 2022: 47 · 2021: 15 · 2020: 1
- FWCI
- 4.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Journal of Endocrinological Investigation (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Università degli Studi di Verona
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Keywords
- polycystic ovary syndrome, insulin resistance, hyperinsulinemia, hyperandrogenism, excess body fat, fetal programming, metabolic abnormalities, reproductive endocrine disorders, pathogenesis
- MeSH terms
- Animals, Female, Humans, Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.